X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (250) 250
index medicus (212) 212
cardiac & cardiovascular systems (195) 195
male (186) 186
female (167) 167
heart failure (161) 161
aged (127) 127
heart failure - drug therapy (122) 122
middle aged (121) 121
mortality (104) 104
acute disease (86) 86
treatment outcome (81) 81
heart failure - physiopathology (76) 76
acute heart failure (62) 62
heart failure - mortality (61) 61
double-blind method (58) 58
prognosis (53) 53
outcomes (52) 52
hospitalization (51) 51
cardiac patients (47) 47
animals (44) 44
risk factors (44) 44
abridged index medicus (41) 41
cardiovascular (41) 41
aged, 80 and over (40) 40
association (40) 40
clinical trials (39) 39
drug therapy (37) 37
heart failure - blood (35) 35
heart failure - therapy (35) 35
heart failure - complications (34) 34
risk (33) 33
heart failure - diagnosis (32) 32
rolofylline (32) 32
article (31) 31
dose-response relationship, drug (30) 30
heart (30) 30
trial (29) 29
biomarkers - blood (28) 28
survival (28) 28
analysis (27) 27
adult (26) 26
cardiology (26) 26
care and treatment (26) 26
double-blind (26) 26
patients (26) 26
biomarkers (25) 25
myocardial-infarction (25) 25
antagonist (23) 23
time factors (23) 23
health aspects (22) 22
medicine, general & internal (22) 22
proportional hazards models (22) 22
serelaxin (22) 22
diuretics (21) 21
dyspnea (21) 21
follow-up studies (21) 21
medical colleges (21) 21
medicine & public health (21) 21
peripheral vascular disease (21) 21
randomized controlled trials as topic (21) 21
research (21) 21
task-force (21) 21
disease (20) 20
dysfunction (20) 20
heart attacks (20) 20
multivariate analysis (20) 20
rats (20) 20
umcg approved (20) 20
heart failure - epidemiology (19) 19
infusions, intravenous (19) 19
prospective studies (19) 19
renal-function (19) 19
stroke (19) 19
survival rate - trends (19) 19
cardiology and cardiovascular medicine (18) 18
clinical-trials (18) 18
disease progression (18) 18
relaxin - therapeutic use (18) 18
therapy (18) 18
arginine - analogs & derivatives (17) 17
blood pressure (17) 17
prevalence (17) 17
xanthines - therapeutic use (17) 17
asymmetric dimethylarginine (16) 16
cardiovascular disease (16) 16
hospitalization - statistics & numerical data (16) 16
nesiritide (16) 16
relax-ahf (16) 16
relaxin - administration & dosage (16) 16
diuretics - therapeutic use (15) 15
management (15) 15
preserved ejection fraction (15) 15
risk assessment (15) 15
united states - epidemiology (15) 15
vasodilator agents - therapeutic use (15) 15
worsening renal-function (15) 15
heart diseases (14) 14
hemodynamics (14) 14
internal medicine (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 02/2018, Volume 137, Issue 9, pp. 961 - 972
This publication describes uniform definitions for cardiovascular and stroke outcomes developed by the Standardized Data Collection for Cardiovascular Trials... 
Cardiovascular endpoints | Outcome definitions | Stroke endpoints | Cardiovascular and stroke endpoint definitions | Cardiovascular and stroke outcome definitions | Endpoint definitions | Cardiovascular outcomes | Clinical trial endpoint definitions | Endpoints | Cardiovascular endpoint definitions | Cardiovascular and stroke outcomes | Clinical trial endpoints | Stroke endpoint definitions | Stroke outcomes | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | cardiovascular outcomes | stroke outcomes | HEALTH-CARE PROFESSIONALS | CONSENSUS DOCUMENT | cardiovascular and stroke outcome definitions | cardiovascular endpoints | stroke endpoint definitions | CARDIAC TROPONIN-T | PERIPHERAL VASCULAR DISEASE | cardiovascular endpoint definitions | cardiovascular and stroke outcomes | stroke endpoints | INTERVENTION | endpoints | MYOCARDIAL-INFARCTION | TRANSIENT ISCHEMIC ATTACK | HEART-FAILURE | clinical trial endpoints | COMMITTEE | endpoint definitions | outcome definitions | UNIVERSAL DEFINITION | cardiovascular and stroke endpoint definitions | clinical trial endpoint definitions | Endpoint Determination - standards | Data Collection - standards | United States | Humans | Stroke - diagnosis | Clinical Trials as Topic | United States Food and Drug Administration | Cardiovascular Diseases - diagnosis | Clinical trials | Outcome and process assessment (Health Care) | Care and treatment | Usage | Cardiovascular diseases | Analysis
Journal Article
LANCET, ISSN 0140-6736, 05/2013, Volume 381, Issue 9880, pp. 1813 - 1814
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 9, pp. 1021 - 1034
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 10/2010, Volume 363, Issue 15, pp. 1419 - 1428
Background: Worsening renal function, which is associated with adverse outcomes, often develops in patients with acute heart failure. Experimental and clinical... 
DIAGNOSIS | KW-3902 | IMPACT | RISK STRATIFICATION | CLINICAL-TRIALS | KIDNEY-FUNCTION | OUTCOMES | UMCG Approved | A RECEPTOR ANTAGONIST | WORSENING RENAL-FUNCTION | IMPAIRMENT | MEDICINE, GENERAL & INTERNAL
Journal Article
European Heart Journal, ISSN 0195-668X, 05/2014, Volume 35, Issue 19, pp. 1284 - +
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 10/2016, Volume 18, Issue 10, pp. 1228 - 1234
Journal Article
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2016, Volume 67, Issue 12, pp. 1444 - 1455
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9792, pp. 676 - 683
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article